Royalty Pharma plcRPRX
那斯達克 · USD
38.81
+0.55
(+1.44%)
收盤 12/12 04:59 (UTC+8)
12/12 04:59 (UTC+8)
Royalty Pharma plcRPRX
38.81
+0.55
(+1.44%)
財務數據
損益表
- 5.38
- 5.36
- 5.96
- 5.68
- 5.37
- 5.65
- 5.94
- 5.68
- 5.79
- 6.09
- -21.31
- -0.35
- 11.14
- -4.71
- -5.41
- 5.10
- 5.13
- -4.28
- 1.83
- 5.29
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 609,291 | 578,665 | 568,247 | 593,641 | 564,690 | 537,267 | 567,978 | 596,068 | 536,313 | 538,202 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 609,291 | 578,665 | 568,247 | 593,641 | 564,690 | - | 567,978 | 596,068 | 536,313 | 538,202 |
營業費用 | 182,135 | 368,867 | - | - | -170,384 | - | 641,752 | -16,828 | 384,871 | 289,362 |
研發費用 | 50,500 | 300,500 | 50,500 | 500 | 500 | 500 | 500 | 500 | 50,500 | 500 |
推銷及管理費用 | 131,635 | 68,367 | -16,435 | 231,627 | -170,884 | 267,137 | 641,252 | -17,328 | 334,371 | 288,862 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 427,156 | 209,798 | 534,182 | 361,514 | 735,074 | 269,630 | -73,774 | 612,896 | 151,442 | 248,840 |
其他收入及費用 | 61,808 | -22,635 | 3,947 | 48,854 | 76,534 | 19,181 | 50,152 | 96,532 | 20,349 | 108,944 |
利息費用 | 79,564 | 68,668 | 65,261 | 65,761 | 66,506 | 49,013 | 44,232 | 47,255 | 46,033 | 46,949 |
稅前純益 | 444,211 | 90,635 | 433,433 | 334,351 | 806,358 | 194,377 | -4,273 | 717,586 | 122,077 | 351,336 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 288,217 | 30,176 | 238,349 | 208,214 | 543,987 | 102,004 | 4,778 | 494,340 | 72,114 | 227,625 |
基本每股稅後盈餘(元) | 0.67 | 0.07 | 0.56 | 0.47 | 1.22 | 0.23 | 0.01 | - | 0.16 | 0.51 |
稀釋每股稅後盈餘(元) | 0.51 | 0.05 | 0.55 | 0.47 | 1.20 | 0.23 | 0.01 | 1.10 | 0.16 | 0.51 |
基本平均股數(千股) | 429027.00 | 432288.00 | 425590.00 | 445985.00 | 446038.00 | 451020.00 | 448623.00 | - | 448439.00 | 450405.00 |
稀釋平均股數(千股) | 560000.00 | 562000.00 | 578000.00 | 589000.00 | 593000.00 | 596912.00 | 597479.00 | - | 601138.00 | 605860.00 |
還原基本每股稅後盈餘(元) | 0.67 | 0.07 | 0.56 | 0.47 | 1.22 | 0.23 | 0.01 | - | 0.16 | 0.51 |
還原稀釋每股稅後盈餘(元) | 0.51 | 0.05 | 0.55 | 0.47 | 1.20 | 0.23 | 0.01 | 1.10 | 0.16 | 0.51 |
還原基本平均股數(千股) | 429,027 | 432,288 | 425,590 | 445,985 | 446,038 | 451,020 | 448,623 | - | 448,439 | 450,405 |
還原稀釋平均股數(千股) | 560,000 | 562,000 | 578,000 | 589,000 | 593,000 | 596,912 | 597,479 | - | 601,138 | 605,860 |
EBITDA(千元) | 367,781 | 98,844 | 303,610 | 273,975 | 610,493 | 151,017 | 49,010 | 541,595 | 118,147 | 274,574 |